✦ LIBER ✦

Use of PEG-asparaginase in the treatment of patients with solid tumors

✍ Scribed by João Vieira Pinheiro; Claudia Lanvers; Joachim Boos

Book ID: 105994744
Publisher: Springer
Year: 2001
Tongue: English
Weight: 45 KB
Volume: 48
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800100361

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I and pharmacodynamic evaluation

A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugatedL-asparaginase in patients with advanced solid tumors

✍ Charles W. Taylor; Robert T. Dorr; Paul Fanta; Evan M. Hersh; Sydney E. Salmon 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 101 KB

The treatment of patients with testicula

The treatment of patients with testicular tumors

✍ William U. Shipley 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 78 KB

The role of chemotherapy in the treatmen

The role of chemotherapy in the treatment of patients with brain metastases from solid tumors

✍ Tobias Walbert; Mark R. Gilbert 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 249 KB

The role of chemotherapy in the treatmen

The role of chemotherapy in the treatment of patients with brain metastases from solid tumors

✍ Jan C. Buckner 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 532 KB

A phase II trial of peg-L-asparaginase i

A phase II trial of peg-L-asparaginase in the treatment of non-hodgkins lymphoma

✍ Hyman B. Muss; Nancy Spell; Diane Scudiery; Robert L. Capizzi; M. Robert Cooper; 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 388 KB

A polyethylene glycol conjugate of L-asparaginase (PEGLA) was administered to 21 patients with refractory non-Hodgkin's lymphoma. The dose given was 2,000 mu/m2 intramuscularly every 2 weeks. Eligibility required at least one prior trial of chemotherapy and ambulatory performance status. At entry, a

Experience with GM-CSF in the treatment

Experience with GM-CSF in the treatment of solid tumors

✍ M. Wolf; K. Havemann 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 635 KB